Shark Fin Sign - 29/01/24
Doi : 10.1016/j.amjmed.2023.10.004
Ryohei Ono, MD, PhD ⁎ 
, Togo Iwahana, MD, PhD, Hirotoshi Kato, MD, PhD, Kaoruko Aoki, MD, Yoshio Kobayashi, MD, PhD
, Togo Iwahana, MD, PhD, Hirotoshi Kato, MD, PhD, Kaoruko Aoki, MD, Yoshio Kobayashi, MD, PhD Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chuo-ku, Japan
⁎Requests for reprints should be addressed to Dr. Ryohei Ono, Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.Department of Cardiovascular MedicineChiba University Graduate School of Medicine1-8-1 InohanaChuo-kuChiba260-8670Japan
| Funding: None. |
|
| Conflict of Interest: None. |
|
| Authorship: All authors had access to the data and a role in writing this manuscript. |
© 2023
Elsevier Inc. Reservados todos los derechos.
Vol 137 - N° 2
P. e35-e37 - février 2024 Regresar al número
Artículo precedente
- Potential Utility of Sodium-Glucose Cotransporter-2 Inhibitors in Treating Myocarditis
- Michael H. Kim, Yash Suri, Iniya Rajendran, J.R. Exequiel T. Pineda
- Antimitochondrial Antibody-Positive Myositis
- Kosuke Ishizuka, Yoshiyuki Ohira
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?